Subscribe Us

header ads

Recents

header ads

Active Pharmaceutical Ingredients Market Size To Hit US$ 363.68 Billion By 2032

Precedence Research - February 28, 2023

The global active pharmaceutical ingredients market size is expected to hit around USD 363.68 billion by 2032 and progressing a CAGR of 6% over the forecast period 2023 to 2032.

Active Pharmaceutical Ingredient Market Size 2023 to 2032

The on active pharmaceutical ingredients Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1035

Report Scope of the Active Pharmaceutical Ingredients Market

Report CoverageDetails
Market SizeUSD 363.68 Billion by 2032
Growth RateCAGR of 6% from 2023 to 2032
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2022
Forecast Period2023 to 2032
Segments CoveredType of Manufacturer, Type, Type of Synthesis, Application, Regional Outlook

A recent report provides crucial insights along with application based and forecast information in the Global Active pharmaceutical ingredients Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Active pharmaceutical ingredients market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Active pharmaceutical ingredients market are included as given below:

Active pharmaceutical ingredients Market Key Players

  • Albemarle Corporation
  • AurobindoPharma
  • Reddy’s Laboratories Ltd.
  • AbbVieInc
  • Teva Pharmaceutical Industries Ltd
  • Mylan N.V.
  • CiplaInc
  • BoehringerIngelheim International GmbH
  • Merck & Co., Inc
  • Sun Pharmaceutical Industries Ltd
  • Bristol-Myers Squibb Company

Market Segments

 By Type of Synthesis

  • Biotech
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
  • Synthetic

By Type of Manufacturer

  • Captive APIs
  • Merchant APIs
    • Generic APIs
    • Innovative APIs

By Type

  • Generic APIs
  • Innovative APIs

By Type of Drug

  • Prescription Drugs
  • Over-the-counter Drugs

By Application

  • Cardiovascular Diseases
  • Oncology
  • CNS & Neurological Disorders
  • Orthopedic Disorders
  • Endocrinology
  • Pulmonology
  • Gastrointestinal Disorders
  • Nephrology
  • Ophthalmology
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East & Africa
  • Latin America

Report Objectives

  • To define, describe, and forecast the global active pharmaceutical ingredients market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the active pharmaceutical ingredients market

Table of Content

 CHAPTER 1. INTRODUCTION 

  • 1.1. RESEARCH OBJECTIVE 
  • 1.2. SCOPE OF THE STUDY 
    • 1.2.1. KEY QUESTIONS ANSWERED IN THE REPORT

CHAPTER 2. RESEARCH METHODOLOGY 

  • 2.1. RESEARCH OBJECTIVE 
  • 2.2. MARKET RESEARCH PROCESS
    • 2.2.1. Data Procurement and Data Mining 
    • 2.2.2. Data Analysis and Standardization 
    • 2.2.3. Data Processing and Market Formulation
    • 2.2.4. Data Validation 
  • 2.3. MARKET RESEARCH APPROACH 
    • 2.3.1. Secondary Research 
    • 2.3.2. Primary Research 
    • 2.3.3. Assumptions & Limitations
  • 2.4. YEAR CONSIDERED FOR THE STUDY

CHAPTER 3. EXECUTIVE SUMMARY 

  • 3.1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SNAPSHOT 
  • 3.2. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET REVENUE 

CHAPTER 4. MARKET VARIABLES AND SCOPE

  • 4.1. INTRODUCTION TO ACTIVE PHARMACEUTICAL INGREDIENTS (API) 
  • 4.2. CLASSIFICATION AND SCOPE

CHAPTER 5. COVID-19 IMPACT ON ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET 

  • 5.1. COVID-19 LANDSCAPE: PRE-COVID ANALYSIS 
  • 5.2. POST COVID-19 ANALYSIS
  • 5.3. COVID-19 IMPACT: GLOBAL MAJOR GOVERNMENT POLICY
  • 5.4. MARKET TRENDS AND OPPORTUNITIES IN THE COVID-19 LANDSCAPE 

CHAPTER 6. MARKET DYNAMICS 

  • 6.1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET DYNAMICS SNAPSHOT
  • 6.2. DRIVERS 
    • 6.2.1. Influence of Precision Medicine 
    • 6.2.2. Increasing Instances of Cardiovascular Diseases 
    • 6.2.3. High Instances of Diabetes
    • 6.2.4. Rising Cases of Strokes 
  • 6.3. RESTRAINTS
    • 6.3.1. High Costs for the Market Growth in some Developing Countries 
    • 6.3.2. Unfavorable Drugs Regulations
  • 6.4. OPPORTUNITY 
    • 6.4.1. Increasing Spending on the Health Sector
  • 6.5. CHALLENGE
    • 6.5.1. Penetration of Counterfeit Drugs 

CHAPTER 7. PREMIUM INSIGHTS 

  • 7.1. PORTER’S FIVE FORCES ANALYSIS 
    • 7.1.1. Bargaining Power of Suppliers 
    • 7.1.2. Bargaining Power of Buyers
    • 7.1.3. Threat of Substitute Products 
    • 7.1.4. Rivalry among Existing Firms
    • 7.1.5. Threat of New Entrants 
  • 7.2. PESTEL ANALYSIS
  • 7.3. VALUE CHAIN ANALYSIS 
    • 7.3.1. Inbound Logistics 
    • 7.3.2. Operations 
    • 7.3.3. Outbound Logistics
    • 7.3.4. Marketing and Sales 
    • 7.3.5. Procurement 
    • 7.3.6. End Users
  • 7.4. VENDOR LANDSCAPE
    • 7.4.1. List of Buyers 
    • 7.4.2. List of Suppliers

CHAPTER 8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET, BY TYPE OF SYNTHESIS

  • 8.1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SNAPSHOT, BY TYPE OF SYNTHESIS
    • 8.1.1. Market Size and Forecast
  • 8.1.2. Biotech 
    • 8.1.2.1. Market Size and Forecast
    • 8.1.2.2. Global Biotech Market, by Type
      • 8.1.2.2.1. Market Size and Forecast
      • 8.1.2.2.2. Monoclonal Antibodies
        • 8.1.2.2.2.1. Market Size and Forecast
      • 8.1.2.2.3. Recombinant Proteins
        • 8.1.2.2.3.1. Market Size and Forecast
      • 8.1.2.2.4. Vaccines
        • 8.1.2.2.4.1. Market Size and Forecast
  • 8.1.3. Synthetic 
    • 8.1.3.1. Market Size and Forecast

CHAPTER 9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET, BY TYPE OF MANUFACTURER

  • 9.1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SNAPSHOT, BY TYPE OF MANUFACTURER
    • 9.1.1. Market Size and Forecast
    • 9.1.2. Captive APIs 
      • 9.1.2.1. Market Size and Forecast
    • 9.1.3. Merchant APIs 
      • 9.1.3.1. Market Size and Forecast
      • 9.1.3.2. Global Merchant APIs Market, by Type
        • 9.1.3.2.1. Market Size and Forecast 
        • 9.1.3.2.2. Generic APIs
          • 9.1.3.2.2.1. Market Size and Forecast
        • 9.1.3.2.3. Innovative APIs
          • 9.1.3.2.3.1. Market Size and Forecast

CHAPTER 10. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET, BY TYPE

  • 10.1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SNAPSHOT, BY TYPE 
    • 10.1.1. Market Size and Forecast
    • 10.1.2. Generic APIs
      • 10.1.2.1. Market Size and Forecast
    • 10.1.3. Innovative APIs 
      • 10.1.3.1. Market Size and Forecast

CHAPTER 11. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET, BY APPLICATION

  • 11.1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SNAPSHOT, BY APPLICATION
    • 11.1.1. Market Size and Forecast
    • 11.1.2. Cardiovascular Diseases 
      • 11.1.2.1. Market Size and Forecast
    • 11.1.3. Oncology
      • 11.1.3.1. Market Size and Forecast
    • 11.1.4. CNS & Neurological Disorders
      • 11.1.4.1. Market Size and Forecast
    • 11.1.5. Orthopedic Disorders 
      • 11.1.5.1. Market Size and Forecast
    • 11.1.6. Endocrinology 
      • 11.1.6.1. Market Size and Forecast
    • 11.1.7. Pulmonology 
      • 11.1.7.1. Market Size and Forecast
    • 11.1.8. Gastrointestinal Disorders
      • 11.1.8.1. Market Size and Forecast
    • 11.1.9. Nephrology
      • 11.1.9.1. Market Size and Forecast
    • 11.1.10. Ophthalmology
      • 11.1.10.1. Market Size and Forecast
    • 11.1.11. Others
      • 11.1.11.1. Market Size and Forecast

CHAPTER 12. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET, BY REGION

  • 12.1. OVERVIEW 
  • 12.2. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET, BY REGION
    • 12.2.1. Market Size and Forecast
  • 12.3. NORTH AMERICA
    • 12.3.1. Market Size and Forecast
    • 12.3.2. North America Active Pharmaceutical Ingredients (API) Market, by Country
    • 12.3.3. North America Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
      • 12.3.3.1. North America Biotech Market, by Type 
    • 12.3.4. North America Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer 
      • 12.3.4.1. North America Merchant APIs Market, by Type 
    • 12.3.5. North America Active Pharmaceutical Ingredients (API) Market, by Type
    • 12.3.6. North America Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.3.7. U.S.
      • 12.3.7.1. Market Size and Forecast
      • 12.3.7.2. U.S. Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
        • 12.3.7.2.1. U.S. Biotech Market, by Type 
      • 12.3.7.3. U.S. Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.3.7.3.1. U.S. Merchant APIs Market, by Type 
      • 12.3.7.4. U.S. Active Pharmaceutical Ingredients (API) Market, by Type 
      • 12.3.7.5. U.S. Active Pharmaceutical Ingredients (API) Market, by Application 
    • 12.3.8. Canada
      • 12.3.8.1. Market Size and Forecast
      • 12.3.8.2. Canada Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
        • 12.3.8.2.1. Canada Biotech Market, by Type
      • 12.3.8.3. Canada Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.3.8.3.1. Canada Merchant APIs Market, by Type
      • 12.3.8.4. Canada Active Pharmaceutical Ingredients (API) Market, by Type 
      • 12.3.8.5. Canada Active Pharmaceutical Ingredients (API) Market, by Application 
    • 12.3.9. Mexico 
      • 12.3.9.1. Market Size and Forecast
      • 12.3.9.2. Mexico Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
        • 12.3.9.2.1. Mexico Biotech Market, by Type
      • 12.3.9.3. Mexico Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.3.9.3.1. Mexico Merchant APIs Market, by Type
      • 12.3.9.4. Mexico Active Pharmaceutical Ingredients (API) Market, by Type 
      • 12.3.9.5. Mexico Active Pharmaceutical Ingredients (API) Market, by Application 
  • 12.4. EUROPE 
    • 12.4.1. Market Size and Forecast
    • 12.4.2. Europe Active Pharmaceutical Ingredients (API) Market, by Country 
    • 12.4.3. Europe Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
      • 12.4.3.1. Europe Biotech Market, by Type 
    • 12.4.4. Europe Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
      • 12.4.4.1. Europe Merchant APIs Market, by Type
    • 12.4.5. Europe Active Pharmaceutical Ingredients (API) Market, by Type 
    • 12.4.6. Europe Active Pharmaceutical Ingredients (API) Market, by Application 
    • 12.4.7. Germany
      • 12.4.7.1. Market Size and Forecast
      • 12.4.7.2. Germany Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
        • 12.4.7.2.1. Germany Biotech Market, by Type
      • 12.4.7.3. Germany Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer 
        • 12.4.7.3.1. Germany Merchant APIs Market, by Type
      • 12.4.7.4. Germany Active Pharmaceutical Ingredients (API) Market, by Type
      • 12.4.7.5. Germany Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.4.8. UK
      • 12.4.8.1. Market Size and Forecast
      • 12.4.8.2. UK Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
        • 12.4.8.2.1. UK Biotech Market, by Type
      • 12.4.8.3. UK Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.4.8.3.1. UK Merchant APIs Market, by Type 
      • 12.4.8.4. UK Active Pharmaceutical Ingredients (API) Market, by Type 
      • 12.4.8.5. UK Active Pharmaceutical Ingredients (API) Market, by Application 
    • 12.4.9. France 
      • 12.4.9.1. Market Size and Forecast
      • 12.4.9.2. France Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
        • 12.4.9.2.1. France Biotech Market, by Type
      • 12.4.9.3. France Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.4.9.3.1. France Merchant APIs Market, by Type
      • 12.4.9.4. France Active Pharmaceutical Ingredients (API) Market, by Type 
      • 12.4.9.5. France Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.4.10. Italy 
      • 12.4.10.1. Market Size and Forecast
      • 12.4.10.2. Italy Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
        • 12.4.10.2.1. Italy Biotech Market, by Type
      • 12.4.10.3. Italy Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.4.10.3.1. Italy Merchant APIs Market, by Type
      • 12.4.10.4. Italy Active Pharmaceutical Ingredients (API) Market, by Type 
      • 12.4.10.5. Italy Active Pharmaceutical Ingredients (API) Market, by Application 
    • 12.4.11. Rest of Europe 
      • 12.4.11.1. Market Size and Forecast
      • 12.4.11.2. Rest of Europe Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
        • 12.4.11.2.1. Rest of Europe Biotech Market, by Type
      • 12.4.11.3. Rest of Europe Active Pharmaceutical Ingredients (API) Market, by Type ofManufacturer
        • 12.4.11.3.1. Rest of Europe Merchant APIs Market, by Type
      • 12.4.11.4. Rest of Europe Active Pharmaceutical Ingredients (API) Market, by Type 
      • 12.4.11.5. Rest of Europe Active Pharmaceutical Ingredients (API) Market, by Application 
  • 12.5. ASIA PACIFIC
    • 12.5.1. Market Size and Forecast
    • 12.5.2. Asia Pacific Active Pharmaceutical Ingredients (API) Market, by Country
    • 12.5.3. Asia Pacific Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
      • 12.5.3.1. Asia Pacific Biotech Market, by Type 
    • 12.5.4. Asia Pacific Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer 
      • 12.5.4.1. Asia Pacific Merchant APIs Market, by Type 
    • 12.5.5. Asia Pacific Active Pharmaceutical Ingredients (API) Market, by Type
    • 12.5.6. Asia Pacific Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.5.7. China 
      • 12.5.7.1. Market Size and Forecast
      • 12.5.7.2. China Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
        • 12.5.7.2.1. China Biotech Market, by Type
      • 12.5.7.3. China Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.5.7.3.1. China Merchant APIs Market, by Type
      • 12.5.7.4. China Active Pharmaceutical Ingredients (API) Market, by Type 
      • 12.5.7.5. China Active Pharmaceutical Ingredients (API) Market, by Application 
    • 12.5.8. India
      • 12.5.8.1. Market Size and Forecast
      • 12.5.8.2. India Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
        • 12.5.8.2.1. India Biotech Market, by Type
      • 12.5.8.3. India Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer 
        • 12.5.8.3.1. India Merchant APIs Market, by Type
      • 12.5.8.4. India Active Pharmaceutical Ingredients (API) Market, by Type
      • 12.5.8.5. India Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.5.9. Japan
      • 12.5.9.1. Market Size and Forecast
      • 12.5.9.2. Japan Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis 
        • 12.5.9.2.1. Japan Biotech Market, by Type
      • 12.5.9.3. Japan Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.5.9.3.1. Japan Merchant APIs Market, by Type
      • 12.5.9.4. Japan Active Pharmaceutical Ingredients (API) Market, by Type
      • 12.5.9.5. Japan Active Pharmaceutical Ingredients (API) Market, by Application 
    • 12.5.10. South Korea
      • 12.5.10.1. Market Size and Forecast
      • 12.5.10.2. South Korea Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
        • 12.5.10.2.1. South Korea Biotech Market, by Type 
      • 12.5.10.3. South Korea Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer 
        • 12.5.10.3.1. South Korea Merchant APIs Market, by Type
      • 12.5.10.4. South Korea Active Pharmaceutical Ingredients (API) Market, by Type
      • 12.5.10.5. South Korea Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.5.11. Rest of Asia Pacific
      • 12.5.11.1. Market Size and Forecast
      • 12.5.11.2. Rest of Asia Pacific Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
        • 12.5.11.2.1. Rest of Asia Pacific Biotech Market, by Type 
      • 12.5.11.3. Rest of Asia Pacific Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.5.11.3.1. Rest of Asia Pacific Merchant APIs Market, by Type
      • 12.5.11.4. Rest of Asia Pacific Active Pharmaceutical Ingredients (API) Market, by Type
      • 12.5.11.5. Rest of Asia Pacific Active Pharmaceutical Ingredients (API) Market, by Application
  • 12.6. LAMEA.
    • 12.6.1. Market Size and Forecast
    • 12.6.2. LAMEA Active Pharmaceutical Ingredients (API) Market, by Country
    • 12.6.3. LAMEA Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
      • 12.6.3.1. LAMEA Biotech Market, by Type
    • 12.6.4. LAMEA Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
      • 12.6.4.1. LAMEA Merchant APIs Market, by Type
    • 12.6.5. LAMEA Active Pharmaceutical Ingredients (API) Market, by Type 
    • 12.6.6. LAMEA Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.6.7. Brazil
      • 12.6.7.1. Market Size and Forecast
      • 12.6.7.2. Brazil Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
        • 12.6.7.2.1. Brazil Biotech Market, by Type 
      • 12.6.7.3. Brazil Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.6.7.3.1. Brazil Merchant APIs Market, by Type
      • 12.6.7.4. Brazil Active Pharmaceutical Ingredients (API) Market, by Type
      • 12.6.7.5. Brazil Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.6.8. Argentina
      • 12.6.8.1. Market Size and Forecast
      • 12.6.8.2. Argentina Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
        • 12.6.8.2.1. Argentina Biotech Market, by Type
      • 12.6.8.3. Argentina Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.6.8.3.1. Argentina Merchant APIs Market, by Type
      • 12.6.8.4. Argentina Active Pharmaceutical Ingredients (API) Market, by Type
      • 12.6.8.5. Argentina Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Market Size and Forecast
      • 12.6.9.2. Saudi Arabia Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
        • 12.6.9.2.1. Saudi Arabia Biotech Market, by Type 
      • 12.6.9.3. Saudi Arabia Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.6.9.3.1. Saudi Arabia Merchant APIs Market, by Type
      • 12.6.9.4. Saudi Arabia Active Pharmaceutical Ingredients (API) Market, by Type
      • 12.6.9.5. Saudi Arabia Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.6.10. South Africa
      • 12.6.10.1. Market Size and Forecast
      • 12.6.10.2. South Africa Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
        • 12.6.10.2.1. South Africa Biotech Market, by Type 
      • 12.6.10.3. South Africa Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer
        • 12.6.10.3.1. South Africa Merchant APIs Market, by Type
      • 12.6.10.4. South Africa Active Pharmaceutical Ingredients (API) Market, by Type
      • 12.6.10.5. South Africa Active Pharmaceutical Ingredients (API) Market, by Application
    • 12.6.11. Rest of LAMEA 
      • 12.6.11.1. Market Size and Forecast
      • 12.6.11.2. Rest of LAMEA Active Pharmaceutical Ingredients (API) Market, by Type of Synthesis
        • 12.6.11.2.1. Rest of LAMEA Biotech Market, by Type
      • 12.6.11.3. Rest of LAMEA Active Pharmaceutical Ingredients (API) Market, by Type of Manufacturer 
        • 12.6.11.3.1. Rest of LAMEA Merchant APIs Market, by Type
      • 12.6.11.4. Rest of LAMEA Active Pharmaceutical Ingredients (API) Market, by Type
      • 12.6.11.5. Rest of LAMEA Active Pharmaceutical Ingredients (API) Market, by Application 

CHAPTER 13. COMPETITIVE LANDSCAPE 

  • 13.1. STRATEGIC MOVE ANALYSIS
    • 13.1.1. Top Winning Strategies by Year, 2019-2022
    • 13.1.2. Top Winning Strategies by Development
    • 13.1.3. Number Of Winning Strategies, by Company, 2019-2022 
    • 13.1.4. Top Winning Strategies, by Company, 2019-2022 
  • 13.2. RECENT DEVELOPMENTS BY THE MARKET PARTICIPANTS (2022)

CHAPTER 14. COMPANY PROFILES 

  • 14.1. AUROBINDO PHARMA
    • 14.1.1. Company Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Financial Performance
    • 14.1.4. Business Overview 
    • 14.1.5. Product Portfolio
    • 14.1.6. Strategic Growth
    • 14.1.7. SWOT Analysis 
  • 14.2. DR. REDDY’S LABORATORIES LTD
    • 14.2.1. Company Overview
    • 14.2.2. Company Snapshot 
    • 14.2.3. Financial Performance
    • 14.2.4. Business Overview 
    • 14.2.5. Product Portfolio.
    • 14.2.6. Strategic Growth
    • 14.2.7. SWOT Analysis 
  • 14.3. ABBVIE INC. 
    • 14.3.1. Company Overview
    • 14.3.2. Company Snapshot 
    • 14.3.3. Financial Performance
    • 14.3.4. Business Overview 
    • 14.3.5. Product Portfolio
    • 14.3.6. Strategic Growth
    • 14.3.7. SWOT Analysis 
  • 14.4. CIPLA INC.
    • 14.4.1. Company Overview
    • 14.4.2. Company Snapshot 
    • 14.4.3. Financial Performance
    • 14.4.4. Business Overview 
    • 14.4.5. Product Portfolio
    • 14.4.6. Strategic Growth
    • 14.4.7. SWOT Analysis 
  • 14.5. ALBEMARLE CORPORATION
    • 14.5.1. Company Overview
    • 14.5.2. Company Snapshot
    • 14.5.3. Financial Performance
    • 14.5.4. Business Overview 
    • 14.5.5. Product Portfolio
    • 14.5.6. Strategic Growth
    • 14.5.7. SWOT Analysis 
  • 14.6. TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • 14.6.1. Company Overview
    • 14.6.2. Company Snapshot 
    • 14.6.3. Financial Performance
    • 14.6.4. Business Overview 
    • 14.6.5. Product Portfolio
    • 14.6.6. Strategic Growth
    • 14.6.7. SWOT Analysis
  • 14.7. VIATRIS INC.
    • 14.7.1. Company Overview
    • 14.7.2. Company Snapshot 
    • 14.7.3. Financial Performance
    • 14.7.4. Business Overview 
    • 14.7.5. Product Portfolio
    • 14.7.6. Strategic Growth
    • 14.7.7. SWOT Analysis
  • 14.8. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • 14.8.1. Company Overview
    • 14.8.2. Company Snapshot
    • 14.8.3. Financial Performance
    • 14.8.4. Business Overview 
    • 14.8.5. Product Portfolio
    • 14.8.6. Strategic Growth
    • 14.8.7. SWOT Analysis 
  • 14.9. SUN PHARMACEUTICAL INDUSTRIES LTD.
    • 14.9.1. Company Overview
    • 14.9.2. Company Snapshot 
    • 14.9.3. Financial Performance
    • 14.9.4. Business Overview 
    • 14.9.5. Product Portfolio
    • 14.9.6. Strategic Growth
    • 14.9.7. SWOT Analysis 
  • 14.10. BRISTOL MYERS SQUIBB COMPANY 
    • 14.10.1. Company Overview
    • 14.10.2. Company Snapshot
    • 14.10.3. Financial Performance
    • 14.10.4. Business Overview 
    • 14.10.5. Product Portfolio clinics 
    • 14.10.6. Strategic Growth
    • 14.10.7. SWOT Analysis 

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments